6.53
price up icon3.49%   0.22
after-market Handel nachbörslich: 6.39 -0.14 -2.14%
loading
Schlusskurs vom Vortag:
$6.31
Offen:
$6.305
24-Stunden-Volumen:
147.16K
Relative Volume:
0.03
Marktkapitalisierung:
$4.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.74M
KGV:
-3.1854
EPS:
-2.05
Netto-Cashflow:
$-8.25M
1W Leistung:
-16.71%
1M Leistung:
+5,030%
6M Leistung:
+2.77%
1J Leistung:
-80.57%
1-Tages-Spanne:
Value
$6.14
$6.70
1-Wochen-Bereich:
Value
$5.22
$7.2499
52-Wochen-Spanne:
Value
$0.0927
$62.60

Glucotrack Inc Stock (GCTK) Company Profile

Name
Firmenname
Glucotrack Inc
Name
Telefon
972 (8) 675-7878
Name
Adresse
301 RT 17 NORTH, RUTHERFORD
Name
Mitarbeiter
11
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
GCTK's Discussions on Twitter

Vergleichen Sie GCTK mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
GCTK
Glucotrack Inc
6.53 4.50M 0 -8.74M -8.25M -2.05
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
540.60 189.82B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
177.27 49.98B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
89.30 44.00B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
255.88 37.05B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
221.22 16.36B 2.90B 467.20M 306.90M 6.37

Glucotrack Inc Aktie (GCTK) Neueste Nachrichten

pulisher
Jun 16, 2025

Glucotrack announces 1:60 reverse stock split - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

GlucoTrack Implements Reverse Stock Split - TipRanks

Jun 16, 2025
pulisher
Jun 13, 2025

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements - mx.advfn.com

Jun 13, 2025
pulisher
Jun 12, 2025

Glucotrack announces 1-for-60 reverse stock split effective June 16 By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Glucotrack announces 1-for-60 reverse stock split effective June 16 - Investing.com Nigeria

Jun 12, 2025
pulisher
Jun 12, 2025

GlucoTrack Announces 1-for-60 Reverse Stock Split - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Glucotrack Implements Major 1-for-60 Reverse Split: What This Means for Your Investment - Stock Titan

Jun 12, 2025
pulisher
Jun 11, 2025

Glucotrack’s Innovative Approach to Diabetes Management Sets New Standards - citybuzz -

Jun 11, 2025
pulisher
Jun 10, 2025

Rebuilding Trust: How Glucotrack Is Establishing A New Standard In Diabetes Management - Nasdaq

Jun 10, 2025
pulisher
Jun 05, 2025

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions - mx.advfn.com

Jun 05, 2025
pulisher
Jun 04, 2025

GlucoTrack to Present at ADA Scientific Sessions - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Revolutionary Diabetes Tech: Glucotrack's 3-Year Implantable Monitor Eliminates Daily Finger Pricks - Stock Titan

Jun 04, 2025
pulisher
May 31, 2025

GCTK stock plunges to 52-week low, hits $0.13 By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 30, 2025

GCTK stock plunges to 52-week low, hits $0.13 - Investing.com India

May 30, 2025
pulisher
May 29, 2025

Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives - The Globe and Mail

May 29, 2025
pulisher
May 29, 2025

Glucotrack appoints new board member with diabetes tech expertise By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 28, 2025

Glucotrack appoints new board member with diabetes tech expertise - Investing.com

May 28, 2025
pulisher
May 28, 2025

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD - The Manila Times

May 28, 2025
pulisher
May 28, 2025

GlucoTrack (NASDAQ:GCTK) Trading Down 0.2% – Time to Sell? - Defense World

May 28, 2025
pulisher
May 23, 2025

GlucoTrack Approves Key Proposals at Annual Meeting - TipRanks

May 23, 2025
pulisher
May 22, 2025

GCTK stock plunges to 52-week low, touches $0.13 - Investing.com Australia

May 22, 2025
pulisher
May 22, 2025

GCTK stock plunges to 52-week low, touches $0.13 By Investing.com - Investing.com Nigeria

May 22, 2025
pulisher
May 20, 2025

GlucoTrack Establishes Patient Advisory Board for CBGM - TipRanks

May 20, 2025
pulisher
May 20, 2025

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development - The Manila Times

May 20, 2025
pulisher
May 20, 2025

Glucotrack, Inc. Forms Patient Advisory Board to Enhance Development of Continuous Blood Glucose Monitor - Nasdaq

May 20, 2025
pulisher
May 20, 2025

Groundbreaking 3-Year Implantable Glucose Monitor Gets Patient-Led Development at Glucotrack - Stock Titan

May 20, 2025
pulisher
May 16, 2025

Glucotrack Reports Q1 2025 Financial Results and Progress - TipRanks

May 16, 2025
pulisher
May 15, 2025

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Innovative Continuous Blood Glucose Monitor Shows Promise in First Human Trial - citybuzz -

May 15, 2025
pulisher
May 14, 2025

GlucoTrack Reports Q1 2025 Financial Results and Progress - TipRanks

May 14, 2025
pulisher
May 14, 2025

Glucotrack, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 14, 2025

Glucotrack, Inc. Advances Continuous Blood Glucose Monitoring Technology with Clinical Study Initiation in Australia by Q3 2025 - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Glucotrack Reports First Quarter 2025 Financial Results And Recent Corporate Highlights - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Breakthrough: Glucotrack's Implantable Diabetes Monitor Hits Clinical Milestone, FDA Decision Expected Q4 - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Glucotrack gains HREC approval for clinical study of CBGM device - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

First-In-Human Study In The Bag, Glucotrack Gears Up For Long-Term Trial Of Potentially Groundbreaking Continuous Blood Glucose Monitor For Diabetes Patients - FinancialContent

May 14, 2025
pulisher
May 13, 2025

Certain Options of GlucoTrack, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2025. - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Certain Common Stock of GlucoTrack, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2025. - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

GlucoTrack Gains Approval for Long-Term Clinical Study - TipRanks

May 13, 2025
pulisher
May 13, 2025

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor - The Manila Times

May 13, 2025
pulisher
May 06, 2025

Geode Capital Management LLC Increases Stock Holdings in GlucoTrack, Inc. (NASDAQ:GCTK) - Defense World

May 06, 2025
pulisher
Apr 30, 2025

GlucoTrack Inc (GCTK) can make a big difference with a little luck - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Medtech CEO Shares Lessons From FIH Implantable Glucose Monitor Trial - Clinical Leader

Apr 30, 2025
pulisher
Apr 29, 2025

GlucoTrack Releases Investor Presentation on April 29 - TipRanks

Apr 29, 2025
pulisher
Apr 29, 2025

GlucoTrack Inc (NASDAQ:GCTK) stock crossing the finish line today - uspostnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Can GlucoTrack Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Apr 29, 2025
pulisher
Apr 29, 2025

Now Is The Time To Build A Position In GlucoTrack Inc (NASDAQ:GCTK) - Marketing Sentinel

Apr 29, 2025

Finanzdaten der Glucotrack Inc-Aktie (GCTK)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$78.25
price up icon 0.46%
$196.98
price up icon 1.39%
medical_instruments_supplies COO
$73.02
price up icon 0.29%
$65.30
price down icon 0.05%
medical_instruments_supplies BAX
$31.13
price down icon 0.32%
medical_instruments_supplies WST
$221.22
price down icon 0.54%
Kapitalisierung:     |  Volumen (24h):